Presentation THT 2026 How Will Guideline Committees View Results From RWE Trials? Presenter: Paul Heidenrich March 04, 2026
Presentation THT 2026 Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF Presenter: Tor Biering-Sørensen March 04, 2026
Presentation THT 2026 Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion Presenter: Robert W. Yeh March 04, 2026
Presentation THT 2026 Time for a Separate Guideline Path for HF Devices? Presenter: Javed Butler March 04, 2026
Presentation THT 2026 Revisiting Surrogate Endpoints in Clinical Trials of HF Devices Presenter: James Januzzi March 04, 2026
Presentation THT 2026 The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies Presenter: Gregg W. Stone March 04, 2026
Presentation THT 2026 Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality? Presenter: John A. Spertus March 04, 2026
Presentation THT 2026 The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved? Presenter: JoAnn Lindenfeld March 04, 2026
Presentation THT 2026 Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial Presenter: Sheldon E. Litwin March 04, 2026
Presentation THT 2026 Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era Presenter: Francis D. Pagani March 04, 2026
Presentation THT 2026 The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials Presenter: Beth A. Davison March 04, 2026
Presentation THT 2026 The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial Presenter: Jeffrey Testani March 04, 2026
Presentation THT 2026 Evaluating Electronic Health Record-Integrated Artificial Intelligence System In Combining Structured and Unstructured Data to Make Clinical Trial Eligibility Determination Presenter: Trejeeve Martyn March 03, 2026
Presentation THT 2026 Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial Presenter: Rami Kahwash March 03, 2026
Presentation THT 2026 Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials Presenter: Mark Darkwah March 03, 2026
Presentation THT 2026 Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial Presenter: Sanjiv J. Shah March 03, 2026
Presentation THT 2026 Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial Presenter: Marat Fudim March 03, 2026
Presentation THT 2026 Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial Presenter: Shamus Husheer March 03, 2026
Presentation THT 2026 Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial Presenter: Grant Reed March 03, 2026
Presentation THT 2026 Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials Presenter: Nelson Wang March 03, 2026